Due to its effectivity in assessing functional capacity and adding prognostic information to the staging of chronic obstructive pulmonary disease (COPD) patients, the 6-min walk test (6MWT) is extensively used in clinical evaluation. Currently, there is little information about the physiological response this test elicits in patients, especially when compared to cardiopulmonary exercise test (CPET). The aim of the study was to compare ventilatory and metabolic responses between these tests commonly used for the assessment of clinical outcome. A group of 20 patients with moderate to very severe COPD were tested for their pulmonary function (flow-volume curve, static lung volumes), occlusion mouth pressures and breath-by-breath measurement of flow, volumes, and oxygen (O2) and carbon dioxide (CO2) concentration during the 6MWT and CPET. All parameters measured during both exercise tests were assessed over the throughout of the tests and compared between each other at specified time points. Serially measured inspiratory vital capacity (IVC) decreased more rapidly and extensively during the walk-test (p ​< ​0,0001). This was accompanied by a limited increase in tidal volume (VT) and minute ventilation (VE), which were significantly lower in the course of the 6MWT (p ​= ​0,0003 and p ​= ​0,0097, respectively). We also noticed a significant decrease in hemoglobin oxygen saturation (SpO2) during the 6MWT which was correlated to percent decrease in IVC (p ​= ​0,0206). Over the course of the 6MWT, oxygen consumption (VO2) and VT reached plateau within 2 ​min, while carbon dioxide production (VCO2) and VE within 3 ​min. During CPET, VO2, VCO2 and VE rose continuously, while VT reached plateau within 4 ​min. The 6MWT seems to be a rather endurance-based test associated with more pronounced dynamic lung hyperinflation and mechanical constraint of ventilation in comparison to cycling.

Departement of Respiratory Medicine 1st Faculty of Medicine Charles University Thomayer Hospital Prague Czech Republic

Pneumo KV Carlsbad Czech Republic

See more in PubMed

Singh D., Agusti A., Anzueto A. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur. Respir. J. 2019;53(5):1900164. PubMed

O’Donnell D.E., Lam M., Webb K. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998;158:1557–1565. PubMed

Pinto-Plata V.M., Cote C., Cabral H., Taylor J., Celli B.R. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur. Respir. J. 2004;23(1):28–33. PubMed

Hopkinson N.S., Toma T.P., Hansell D.M. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am. J. Respir. Crit. Care Med. 2005;171(5):453–460. PubMed

Palange P., Forte S., Onorati P., Manfredi F., Serra P., Carlone S. Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. J. Appl. Physiol. 2000;88(5):1715–1720. PubMed

Troosters T., Vilaro J., Rabinovich R. Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur. Respir. J. 2002;20(3):564–569. PubMed

Turner S.E., Eastwood P.R., Cecins N.M., Hillman D.R., Jenkins S.C. Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest. 2004;126(3):766–773. PubMed

Miller M.R., Hankinson J., Brusasco V. Standardisation of spirometry. Eur. Respir. J. 2005;26(2):319–338. PubMed

Wanger J., Clausen J.L., Coates a. Standardisation of the measurement of lung volumes. Eur Respir J Off J Eur Soc Clin Respir Physiol. 2005;26(3):511–522. PubMed

Macintyre N., Crapo R.O., Viegi G. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J Off J Eur Soc Clin Respir Physiol. 2005;26(4):720–735. PubMed

Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., Yernault J.-C. Lung volumes and forced ventilaroty flows. Eur. Respir. J. 1993;6(Suppl.16):5–14. PubMed

Gibson G.J., Whitelaw W., Siafakas N. ATS/ERS statement on respiratory muscle testing. Am. J. Respir. Crit. Care Med. 2002;166(4):518–624. PubMed

Black L.F., Hyatt R.E. Maximal respiratory pressures: normal values and relationship to age and sex. Am. Rev. Respir. Dis. 1969;99(5):696–702. PubMed

Hayot M., Ramonatxo M., Matecki S., Milic-Emili J., Prefaut C. Noninvasive assessment of inspiratory muscle function during exercise. Am. J. Respir. Crit. Care Med. 2000;162(6):2201–2207. PubMed

Enright P.L. The six-minute walk test. Respir. Care. 2003;48(8):783–785. PubMed

Holland a. E., Spruit M.a., Troosters T. An official European Respiratory Society/American Thoracic Society Technical Standard: field walking tests in chronic respiratory disease. Eur. Respir. J. 2014;44(6):1428–1446. PubMed

Weisman I.M., Marciniuk D., Martinez F.J. ATS/ACCP Statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2003;167(2):211–277. PubMed

O’Donnell D.E., Elbehairy A.F., Faisal A., Webb K.A., Neder J.A., Mahler D.A. Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing. Eur. Respir. Rev. 2016;25(141):333–347. PubMed PMC

Calverley PM a. Exercise and dyspnoea in COPD. Eur. Respir. Rev. 2006;15(100):72–79.

Chlumsky J., Filipova P., Terl M. Non-invasive assessment of respiratory muscle function and its relationship to exercise tolerance in patients with chronic obstructive pulmonary disease. J. Int. Med. Res. 2006;34:240–246. PubMed

Díaz O., Villafranca C., Ghezzo H. Breathing pattern and gas exchange at peak exercise in COPD patients with and without tidal flow limitation at rest. Eur. Respir. J. 2001;17(6):1120–1127. PubMed

Kortianou E.A., Aliverti A., Louvaris Z. Limitation in tidal volume expansion partially determines the intensity of physical activity in COPD. J. Appl. Physiol. 2015;118:107–114. PubMed

Garcia-Rio F., Lores V., Mediano O. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am. J. Respir. Crit. Care Med. 2009;180(6):506–512. PubMed

Miles D., Critz J., Knowlton R. Cardiovascular, metabolic, and ventilatory responses of women to equivalent cycle ergometer and treadmill exercise. Med. Sci. Sports Exerc. 1980;12(1):14–19. PubMed

Baarends E.M., Schols A.M.W.J., Mostert R., Janssen P.P., Wouters E.F.M. Analysis of the metabolic and ventilatory response to self-paced 12-minute treadmill walking in patients with severe chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 1998;18(1):23–31. PubMed

O’Donnell D.E., Revill S.M., Webb K a. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001;164(5):770–777. PubMed

Yan S., Kaminski D., Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in. Am. J. Respir. Crit. Care Med. 1997;156:55–59. PubMed

Johnson B.D. Emerging concepts in the evaluation of ventilatory limitation during exercise: the exercise tidal flow-volume loop. Chest. 1999;116(2):488. PubMed

Mak V.H., Bugler J.R., Roberts C.M., Spiro S.G. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Thorax. 1993;48(1):33–38. PubMed PMC

Poulain M., Durand F., Palomba B. 6-Minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest. 2003;123(5):1401–1407. PubMed

Marin J.M., Carrizo S.J., Gascon M., Sanchez A., Gallego B., Celli B.R. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001;163(6):1395–1399. PubMed